News & events


April 26, 2017 1pm EST

Going Beyond RECIST – How Volumetric and Functional Analysis Can Add Value to Your Oncology Clinical Trials

Hosted by: Median Technologies

Presented by:  Dr. Robert Ford, Clinical Trials Imaging Consulting, LLC

April 26, 2017 at 1pm EST

Three-dimensional, volume-based measurements address some of the inherent limitations of unidimensional RECIST measurements, provide additional measures of efficacy for modern drug classes, and allow for earlier detection of therapeutic response. Early studies indicate that volume-based measurements are both medically meaningful and add value to a clinical trial. Volume measurements can be easily incorporated into existing clinical trial workflows using segmentation software, that also improves trial efficiency and reproducibility.

What you will learn in this webinar:

The Difference between Routine Versus Advanced Endpoints

More about Volume-Based Endpoints and When to Use Them;

Making Volumetric Tumor Measurements:The Nuts and Bolts

Adding Value to Clinical Trials: Are Volumetric Assessments a True Reflection of Drug Response?

Register today!

Register Here
See all webinars

Press releases

See all press releases


June 19 - 22, San Diego, CA

Bio International Convention 2017

Median will be presenting at and participating in the Bio International Convention 2017 on June 19 – 22. Please join us in the France Pavilion # 3217 and at our interactive panel discussion on ”The Oncology Phase 1 Trial of the Future: Delivering Promising Drugs More Efficiently and Rapidly”.

Visit conference website

Visit conference website
See all conferences


See all blog entries

Cookies help us deliver our services. By using our services, you agree to our use of cookies.